Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficient and valid large molecule generation via self-supervised generative models.

npj drug discovery·2026
Same author

An integrated computational antigen discovery pipeline with hierarchical filtering for emerging viral variants.

NAR molecular medicine·2026
Same author

Enhancing protein immunogenicity prediction via uncertainty weighted deep ensemble.

Oxford open immunology·2026
Same author

Variable rate neural compression for sparse detector data.

Patterns (New York, N.Y.)·2026
Same author

ImmUQBench: a benchmark on uncertainty quantification of protein immunogenicity prediction.

Oxford open immunology·2026
Same author

Epidemiological model calibration via graybox Bayesian optimization.

Infectious Disease Modelling·2026

Related Experiment Video

Updated: May 17, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Adaptive reference update (ARU) algorithm. A stochastic search algorithm for efficient optimization of multi-drug

Mansuck Kim1, Byung-Jun Yoon

  • 1Department of Electrical and Computer Engineering, Texas A&M University, College Station, TX 77843-3128, USA.

BMC Genomics
|November 9, 2012
PubMed
Summary

Optimizing multi-drug therapies is challenging. The novel adaptive reference update (ARU) algorithm efficiently identifies potent drug combinations, outperforming existing methods and adapting to complex response functions.

More Related Videos

Optimization of Radiochemical Reactions using Droplet Arrays
10:54

Optimization of Radiochemical Reactions using Droplet Arrays

Published on: February 12, 2021

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Related Experiment Videos

Last Updated: May 17, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Optimization of Radiochemical Reactions using Droplet Arrays
10:54

Optimization of Radiochemical Reactions using Droplet Arrays

Published on: February 12, 2021

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Area of Science:

  • Pharmacology
  • Computational Biology
  • Biostatistics

Background:

  • Multi-target therapeutics are crucial for complex diseases.
  • Combining drugs optimizes therapeutic outcomes but poses combinatorial challenges.
  • Exhaustive testing for optimal drug combinations is practically infeasible.

Purpose of the Study:

  • To introduce a novel stochastic search algorithm for optimizing multi-drug cocktails.
  • To provide an efficient and systematic method for drug combination optimization.

Main Methods:

  • Proposed the adaptive reference update (ARU) algorithm, a stochastic search method.
  • ARU iteratively updates drug combinations by comparing current and reference responses.
  • The reference combination is continuously updated based on past drug response data.

Main Results:

  • ARU algorithm significantly outperforms existing stochastic search algorithms, including the Gur Game algorithm.
  • ARU effectively identifies potent drug combinations with fewer iterations.
  • The algorithm demonstrates robustness to noise in drug response measurements.

Conclusions:

  • The ARU algorithm offers an efficient and systematic approach to multi-drug combination optimization.
  • Its performance and robustness make it suitable for practical drug discovery and development.
  • ARU accelerates the identification of effective therapeutic combinations.